학술논문
Safety and efficacy of BAY 94-9027, an extended-half-life factor VIII, during surgery in patients with severe hemophilia A: Results of the PROTECT VIII clinical trial
Document Type
Article
Author
Source
In: Thrombosis Research . (Thrombosis Research, November 2019, 183:13-19)
Subject
Language
English
ISSN
18792472
00493848
00493848